Pharmaceutical development of sangviritrin spray for the treatment of inflammatory diseases of the oral cavity

Introduction. One of the most common bacterial infections includes acute and chronic tonsillitis, affecting 10 to 15 % of adults and approximately 20–25 % of children worldwide, according to the World Health Organization. The focus of this study was an original substance, sangviritrin, containing no...

Full description

Saved in:
Bibliographic Details
Main Authors: M. N. Anurova, Ya. A. Dorokhina, A. S. Gulenkov, N. B. Demina, L. A. Korol, P. G. Mizina
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2025-03-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/2013
Tags: Add Tag
No Tags, Be the first to tag this record!